Skip to main content
OpenTrials

Clinical trial condition

Unresectable Melanoma

Explore clinical trials studying Unresectable Melanoma. Study availability and eligibility vary by location and protocol.

52 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Unresectable Melanoma trial results

Active, Not Recruiting

Testing the Addition of Navitoclax to the Combination of Dabrafenib and Trametinib in People Who Have BRAF Mutant Melanoma

NCT01989585

Conditions
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Malignant Solid Neoplasm, +14 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 49 locations
View Trial Details
Active, Not Recruiting

Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers

NCT03816332

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Basal Cell, +42 more
Locations
  • Moffitt Cancer Center - McKinley Campus Tampa, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern University Chicago, Illinois, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
View Trial Details
Active, Not Recruiting

Talimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV Melanoma

NCT02965716

Conditions
Advanced Melanoma, Melanoma, Neoplasms, +17 more
Locations
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • CTCA at Western Regional Medical Center Goodyear, Arizona, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 20 locations
View Trial Details
Active, Not Recruiting

A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma

NCT07288203

Conditions
Melanoma, Melanoma (Skin Cancer), Metastatic Melanoma, +12 more
Locations
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • Greenslopes Private Hospital Greenslopes, Queensland, Australia
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada, Canada
  • Centre Hospitalier de l'Universite de Montreal Montral, Quebec, Canada, Canada
View Trial Details
Active, Not Recruiting

A Single Arm Trial Evaluating the Efficacy and Safety of EVX-01 in Combination With Pembrolizumab in Adults With Unresectable or Metastatic Melanoma

NCT05309421

Conditions
Melanoma, Melanoma Stage IV, Neoplasms, +11 more
Locations
  • Melanoma Institute Australia Wollstonecraft, New South Wales, Australia
  • One Clinical Research Nedlands, Western Australia, Australia
  • Divisione di Oncologia Medica del Melanoma Milan, Italy
  • Instituto Nazionale Tumori IRCCS Fondazione Naples, Italy
View Trial Details

Related conditions